Osteogenezi̇s i̇mperfektali bi̇r hastaya uygulanan total i̇ntravenöz anestezi̇de deksmedetomi̇di̇n kullanimi

Translated title of the contribution: Dexmedetomidine use in total intravenous anesthesia in a case with osteogenesis imperfecta

Nesrin Bozdoǧan, H. Evren Eker, Oya Yalçin Çok, Şule Akin, Murat Çinar, Gürkan Özkoç, Aniş Ariboǧan

Research output: Contribution to journalArticlepeer-review


Osteogenesis imperfecta (OI) is a rare connective tissue disease that primarily appears in bone, preceded with collagen abnormalities, characterized genetically. During the anesthetic management of these patients, intubation difficulties, cervical spine fractures, and malignant hyperthermia triggered by used anesthetic agents may develop. Taking the necessary measures in these patients, avoiding formation of new fractures during airway management, and to prevent hyperthermia intravenous agents can be thought instead of inhalation agents. Dexmedetomidine, is a sedative agent that provides smooth extubation conditions, and can be applied to TIVA as a third agent due to this property. In this case, we present our experience for adding dexmedetomidine to total intravenous anesthesia as an adjuvant to the patient with OI undergoing orthopedic surgery.

Translated title of the contributionDexmedetomidine use in total intravenous anesthesia in a case with osteogenesis imperfecta
Original languageTurkish
Pages (from-to)186-188
Number of pages3
JournalAnestezi Dergisi
Issue number3
StatePublished - 2012

All Science Journal Classification (ASJC) codes

  • Anesthesiology and Pain Medicine

Cite this